Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of pathogenic germline variants in the circulating tumor DNA testing.
Yamamoto Y, Fukuyama K, Kanai M, Kondo T, Yoshioka M, Kou T, Quy PN, Kimura-Tsuchiya R, Yamada T, Matsumoto S, Kosugi S, Muto M. Yamamoto Y, et al. Among authors: kou t. Int J Clin Oncol. 2022 Oct;27(10):1554-1561. doi: 10.1007/s10147-022-02220-x. Epub 2022 Jul 23. Int J Clin Oncol. 2022. PMID: 35870019 Free PMC article.
Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.
Yamada A, Horimatsu T, Okugawa Y, Nishida N, Honjo H, Ida H, Kou T, Kusaka T, Sasaki Y, Yagi M, Higurashi T, Yukawa N, Amanuma Y, Kikuchi O, Muto M, Ueno Y, Nakajima A, Chiba T, Boland CR, Goel A. Yamada A, et al. Among authors: kou t. Clin Cancer Res. 2015 Sep 15;21(18):4234-42. doi: 10.1158/1078-0432.CCR-14-2793. Epub 2015 Jun 2. Clin Cancer Res. 2015. PMID: 26038573 Free PMC article.
Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy.
Kou T, Kanai M, Yamamoto M, Xue P, Mori Y, Kudo Y, Kurita A, Uza N, Kodama Y, Asada M, Kawaguchi M, Masui T, Mizumoto M, Yazumi S, Matsumoto S, Takaori K, Morita S, Muto M, Uemoto S, Chiba T. Kou T, et al. Int J Clin Oncol. 2016 Feb;21(1):118-25. doi: 10.1007/s10147-015-0864-x. Epub 2015 Jun 28. Int J Clin Oncol. 2016. PMID: 26123314
Clinical sequencing using a next-generation sequencing-based multiplex gene assay in patients with advanced solid tumors.
Kou T, Kanai M, Yamamoto Y, Kamada M, Nakatsui M, Sakuma T, Mochizuki H, Hiroshima A, Sugiyama A, Nakamura E, Miyake H, Minamiguchi S, Takaori K, Matsumoto S, Haga H, Seno H, Kosugi S, Okuno Y, Muto M. Kou T, et al. Cancer Sci. 2017 Jul;108(7):1440-1446. doi: 10.1111/cas.13265. Epub 2017 May 22. Cancer Sci. 2017. PMID: 28440963 Free PMC article.
Association Between Preanalytical Factors and Tumor Mutational Burden Estimated by Next-Generation Sequencing-Based Multiplex Gene Panel Assay.
Quy PN, Kanai M, Fukuyama K, Kou T, Kondo T, Yamamoto Y, Matsubara J, Hiroshima A, Mochizuki H, Sakuma T, Kamada M, Nakatsui M, Eso Y, Seno H, Masui T, Takaori K, Minamiguchi S, Matsumoto S, Muto M. Quy PN, et al. Among authors: kou t. Oncologist. 2019 Dec;24(12):e1401-e1408. doi: 10.1634/theoncologist.2018-0587. Epub 2019 Jun 11. Oncologist. 2019. PMID: 31186376 Free PMC article.
155 results